News

Strong messages on enhancing competitiveness and attracting investment to Greece through targeted initiatives and a unified direction across all stakeholders Athens, April 27, 2026 — The panel discussion on clinical research at the 11th Delphi Economic Forum concluded with great success, highlighting the prospects for strengthening Greece’s position on the European map. The session titled “Clinical Trials in Europe: Competitiveness, Access and Innovation,” held on the initiative of HACRO, made it explicitly clear that Greece is entering a new, more mature phase, marked by strong prospects for attracting investment in clinical research. At her speech, HACRO President Evangelia Koraki, ...

HACRO participated in the scientific conference organized by the National Organization for Medicines (EOF) on Wednesday, February 4, 2026, titled “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps.” The President, Ms. Evangelia Koraki, in her presentation entitled “The pivotal role of EOF in the progress of clinical research in Greece” highlighted the multiple benefits of clinical trials for patients and the country, and emphasized the central role of EOF in protecting patients’ rights and safety, ensuring data reliability as well as enhancing Greece’s attractiveness as a destination for conducting clinical trials. The presentation is available ...

The Greek Patients’ Association launches the first EUPATI Patient Academy in Greece (https://academy.greekpatient.gr/), a comprehensive educational program aimed at strengthening the role of patients in pharmaceutical research, clinical trials, and health policy development. Empowering patients through continuous education and access to reliable information can play a decisive role in shaping a modern, equitable, and efficient healthcare system—one in which patients’ voices have a meaningful impact not only on decisions regarding their treatment and care, but also on the improvement of services and the design of effective health policies. In this context, HACRO supports initiatives that promote the active participation ...

Rare Diseases Greece presents three groundbreaking, interactive tools that offer valuable support to individuals living with rare diseases in Greece. These tools aim to improve access to therapies, advocate for patient rights, and enhance understanding of the rare disease landscape in the country. These tools promote transparency and empower citizens to actively participate in the management of their health and care. More information is available on the official website of Rare Diseases Greece: rarediseasesgreece.gr

The new Clinical Trial Map, made available by the European Medicines Agency (EMA) through the public online platform CTIS, represents a particularly significant advancement in the field of clinical research in Europe. This innovative and effective tool enables patients and healthcare professionals to identify, in real-time, ongoing clinical trials across Europe by geographic region and medical condition, along with relevant investigator details, thus providing comprehensive information and facilitating enrollment opportunities for interested parties. The Clinical Trial Map reflects Europe’s goal of advancing clinical research across the continent and underscores its commitment to transparency in clinical trials. https://euclinicaltrials.eu/search-for-clinical-trials/trial-map/?lang=en